All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
The virtual Lymphoma Hub Satellite Symposium, at the 16th International Conference on Malignant Lymphoma (16-ICML), saw a panel of international experts come together to discuss the sequencing of therapies in high-risk relapsed/refractory lymphoma and chronic lymphocytic leukemia. Professor Loretta J. Nastoupil, MD Anderson Cancer Center, Houston, US, discusses how to treat early relapse in a patient with follicular lymphoma (FL).
Welcome to the Lymphoma Hub Satellite Symposium.
Please take a moment to complete the survey and answer the following questions to help us gauge your current understanding of the sequencing of therapy for patients with early relapsing FL.
Nastoupil begins by outlining a clinical case and the benefits of utilizing PET scans to exclude transformation as the driver of poor outcomes. The presentation then reviews therapeutic options and the data that inform treatment selection, including data from the GADOLIN, AUGMENT, GALEN, and SWOG trials. Finally, Nastoupil describes how she would approach this case, utilizing available clinical trials that employ novel agents, such as tazemetostat and tafasitamab, and she offers insight for those that practice in a different setting.
Satellite Symposium | How to treat early relapse in a patient with FL
If you would like to download the slides from Loretta Nastoupil's presentation, click belowDownload here
Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches for the treatment of lymphoid malignancies - Professor Nathan Fowler
Professor Nathan Fowler, University of Texas MD Anderson Cancer Centre, Houston, US, presented the current state of...
Lymphoma Hub Satellite Symposium 2021: Summary and roundtable discussion
On Friday, June 18, 2021, at the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub hosted a virtual satellite symposium on the sequencing of...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox